BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 8667367)

  • 1. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
    Numazawa M; Kamiyama T; Tachibana M; Oshibe M
    J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors.
    Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA
    Steroids; 2008 Dec; 73(14):1409-15. PubMed ID: 18691607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-dependent inactivation of aromatase by 6-alkylandrosta-1,4-diene-3,17-diones. Effects of length and configuration of 6-alkyl group.
    Numazawa M; Oshibe M; Yamaguchi S; Tachibana M
    J Med Chem; 1996 Mar; 39(5):1033-8. PubMed ID: 8676338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies on 6-alkylandrost-4-ene-3,17-diones as aromatase inhibitors: elongation of the 6-alkyl chain.
    Numazawa M; Oshibe M
    Steroids; 1995 Aug; 60(8):506-11. PubMed ID: 8539792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6 beta-Propynyl-substituted steroids: mechanism-based enzyme-activated irreversible inhibitors of aromatase.
    Akkani A; Paterlini G; Gleason WB; Ojala WH; Abul-Hajj YJ
    J Med Chem; 1997 Sep; 40(20):3263-70. PubMed ID: 9379446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Alkyl- and 6-arylandrost-4-ene-3,17-diones as aromatase inhibitors. Synthesis and structure-activity relationships.
    Numazawa M; Oshibe M
    J Med Chem; 1994 Apr; 37(9):1312-9. PubMed ID: 8176709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-Phenylaliphatic-substituted androst-4-ene-3,17-diones as aromatase inhibitors: structure-activity relationships.
    Numazawa M; Yamaguchi S
    J Steroid Biochem Mol Biol; 1998 Oct; 67(1):41-8. PubMed ID: 9780028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted C19 steroid analogs as inhibitors of aromatase.
    Brueggemeier RW; Snider CE; Counsell RE
    Cancer Res; 1982 Aug; 42(8 Suppl):3334s-3337s. PubMed ID: 7083196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A- or B-ring-substituted derivatives of androst-4-ene-3,6,17-trione as aromatase inhibitors. Structure-activity relationships.
    Numazawa M; Tachibana M
    Steroids; 1994 Oct; 59(10):579-85. PubMed ID: 7878685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6 alpha,7 alpha-cyclopropane derivatives of androst-4-ene: a novel class of competitive aromatase inhibitors.
    Numazawa M; Mutsumi A
    Biochem Biophys Res Commun; 1991 May; 177(1):401-6. PubMed ID: 2043124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biochemical studies of 16- or 19-substituted androst-4-enes as aromatase inhibitors.
    Numazawa M; Mutsumi A; Hoshi K; Oshibe M; Ishikawa E; Kigawa H
    J Med Chem; 1991 Aug; 34(8):2496-504. PubMed ID: 1875347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of a new family of steroidal aromatase inhibitors. 1. Synthesis and evaluation of a series of analogs related to 19-[(methylthio)methyl]androstenedione (RU54115).
    Lesuisse D; Gourvest JF; Benslimane O; Canu F; Delaisi C; Doucet B; Hartmann C; Lefrançois JM; Tric B; Mansuy D; Philibert D; Teutsch G
    J Med Chem; 1996 Feb; 39(3):757-72. PubMed ID: 8576919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Oxygenated androst-5-en-17-ones and their 7-oxo derivatives as aromatase inhibitors.
    Numazawa M; Tachibana M; Tateda Y
    J Steroid Biochem Mol Biol; 1996 Jul; 58(4):431-8. PubMed ID: 8903428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymic aromatization of 6-alkyl-substituted androgens, potent competitive and mechanism-based inhibitors of aromatase.
    Numazawa M; Yoshimura A; Oshibe M
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):151-6. PubMed ID: 9405288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of 2alpha-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions.
    Numazawa M; Handa W; Hasegawa C; Takahashi M
    J Steroid Biochem Mol Biol; 2005 Dec; 97(4):353-9. PubMed ID: 16209922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of androst-5-en-7-ones and androsta-3,5-dien-7-ones and their related 7-deoxy analogs as conformational and catalytic probes for the active site of aromatase.
    Numazawa M; Mutsumi A; Tachibana M; Hoshi K
    J Med Chem; 1994 Jul; 37(14):2198-205. PubMed ID: 8035427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemistry and pharmacology of 7alpha-substituted androstenediones as aromatase inhibitors.
    Brueggemeier RW; O'Reilly JM; Lovely CJ; Ward PJ; Quinn AL; Baker D; Darby MV; Gu XJ; Gilbert NE
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):247-54. PubMed ID: 9365197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of 3-deoxy androgens as aromatase inhibitors. Synthesis and biochemical studies of 4-substituted 4-ene and 5-ene steroids.
    Nagaoka M; Watari Y; Yajima H; Tsukioka K; Muroi Y; Yamada K; Numazawa M
    Steroids; 2003 Aug; 68(6):533-42. PubMed ID: 12906938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the binding pocket of the active site of aromatase with 6-ether or 6-ester substituted androst-4-ene-3,17-diones and their diene and triene analogs.
    Numazawa M; Shelangouski M; Nagasaka M
    Steroids; 2000 Dec; 65(12):871-82. PubMed ID: 11077085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of some epoxy and/or N-oxy 17-picolyl and 17-picolinylidene-androst-5-ene derivatives and evaluation of their biological activity.
    Djurendić E; Daljev J; Sakac M; Canadi J; Santa SJ; Andrić S; Klisurić O; Kojić V; Bogdanović G; Djurendić-Brenesel M; Novaković S; Gasi KP
    Steroids; 2008 Jan; 73(1):129-38. PubMed ID: 17963806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.